FDG PET/CT in the staging of lung cancer
Volume 13, Issue 3, January 2020, Pages 195-203
Toward the discovery and development of PSMA targeted inhibitors for nuclear medicine applications
Volume 13, Issue 1, January 2020, Pages 63-79
Lung cancer and radiological imaging
Volume 13, Issue 3, January 2020, Pages 238-242
Effect of Nano-Curcumin on Radiotherapy-Induced Skin Reaction in Breast Cancer Patients: A Randomized, Triple-Blind, Placebo-Controlled Trial
Volume 15, Issue 4, December 2022, Pages 332-340
99mtc-edda/hynic-toc is a new opportunity in neuroendocrine tumors of the lung (And in other malignant and benign pulmonary diseases)
Volume 13, Issue 3, January 2020, Pages 166-176
Potential of radiolabeled PSMA PET/CT or PET/MRI diagnostic procedures in gliomas/glioblastomas
Volume 13, Issue 2, January 2020, Pages 94-98
18f-fdg pet/ct in restaging and evaluation of response to therapy in lung cancer: State of the art
Volume 13, Issue 3, January 2020, Pages 228-237
Cyclotron Production of PET Radiometals in Liquid Targets: Aspects and Prospects
Volume 14, Issue 4, December 2021, Pages 325-339
In situ generated212 pb-psma ligand in a224 ra-solution for dual targeting of prostate cancer sclerotic stroma and psma-positive cells
Volume 13, Issue 2, January 2020, Pages 130-141
Sentinel node identification in melanoma: Current clinical impact, new emerging SPECT radiotracers and technological advancements. an update of the last decade
Volume 13, Issue 1, January 2020, Pages 32-41
Pet/ct and the response to immunotherapy in lung cancer
Volume 13, Issue 3, January 2020, Pages 177-184
IAEA Activities on 67Cu,186Re,47Sc Theranostic Radionuclides and Radiopharmaceuticals
Volume 14, Issue 4, December 2021, Pages 306-314
Accelerator Production of Scandium Radioisotopes: Sc-43, Sc-44, and Sc-47
Volume 14, Issue 4, January 2021, Pages 359-373
Meitner-Auger Electron Emitters for Targeted Radionuclide Therapy: Mercury-197m/g and Antimony-119
Volume 14, Issue 4, January 2021, Pages 394-419
A Review of Accelerator-Produced Ga-68 with Solid Targets
Volume 14, Issue 4, December 2021, Pages 315-324
Alternative and new radiopharmaceutical agents for lung cancer
Volume 13, Issue 3, January 2020, Pages 185-194
Calcium carbonate microparticles as carriers of224ra: Impact of specific activity in mice with intraperitoneal ovarian cancer
Volume 14, Issue 2, January 2021, Pages 145-153
Artificial neural networks in cardiovascular diseases and its potential for clinical application in molecular imaging
Volume 14, Issue 3, January 2021, Pages 209-219
Discovery and Design of Radiopharmaceuticals by In silico Methods
Volume 15, Issue 4, December 2022, Pages 271-319
Histopathological Evaluation of Nanocurcumin for Mitigation of Radiation-Induced Small Intestine Injury
Volume 16, Issue 1, March 2023, Pages 57-63
Ferroptosis Inducers as Promising Radiosensitizer Agents in Cancer Radiotherapy
Volume 17, Issue 1, January 2024, Pages 14-29
Evidence-based data about prevalence and risk of malignancy of thyroid incidentalomas detected by different PET radiopharmaceuticals
Volume 13, Issue 2, January 2020, Pages 89-93
Cardiac Injury Following Chemo/Radiation Therapy: An Updated Review on Mechanisms and Therapeutic Approaches
Volume 16, Issue 3, January 2023, Pages 185-203
Imperatorin Attenuates the Proliferation of MCF-7 Cells in Combination with Radiotherapy or Hyperthermia
Volume 15, Issue 3, September 2022, Pages 236-241
Oxidant and antioxidant effects of gentisic acid in a 177Lu-labelled methionine-containing minigastrin analogue
Volume 13, Issue 2, January 2020, Pages 107-119